Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06992544 · ClinicalTrials.gov registry record · NA
Trial of Pistachio Consumption in Older Adults
A NA study of Cognition and Cardiometabolic Risk Factors, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 97
- Enrollment target
- 1
- Study location
NCT06992544: Active NA study of Cognition and Cardiometabolic Risk Factors, sponsored by Brigham and Women's Hospital.
NCT06992544 is a NA study of Cognition and Cardiometabolic Risk Factors that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 97 participants, below the 169-participant average among 35 other Cognition trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06992544, a NA study of Cognition and Cardiometabolic Risk Factors, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate whether a pistachio-enriched diet leads to changes in cognitive function, cardiometabolic risk factors, and life satisfaction in older adults over a 6-month period.
Primary Outcome
The investigators will assess 6-month changes in the Mobile Toolbox (MTB) fluid cognition composite (FCC) score via MyCap. Participants will be instructed to install the MyCap app on their personal smartphones to complete the assessments. The FCC score considers the following domains (tests): associative memory (Face and Names), episodic memory (Arranging Pictures), working memory (Sequences), processing speed (Number-Symbol Match), and executive function (Arrow Matching for inhibitory control,
Conditions Studied
Interventions
- OTHER Pistachio-enriched diet
- OTHER Usual diet
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2025-05-28 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT06992544 still lists
NCT06992544 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 169-participant average among 35 other Cognition trials with a reported enrollment target (43% lower).
The record links to 3 conditions, with Cognition appearing as the primary indexed condition, and to 2 interventions - of which Pistachio-enriched diet is the first listed.
NCT06992544 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06992544 about?
NCT06992544 is a clinical study titled "Trial of Pistachio Consumption in Older Adults". The goal of this study is to evaluate whether a pistachio-enriched diet leads to changes in cognitive function, cardiometabolic risk factors, and life satisfaction in older adults over a 6-month period.
What is the current status of trial NCT06992544?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 97 participants. The study started on 2025-05-28. Estimated completion is 2026-06.
What conditions does trial NCT06992544 study?
This clinical trial studies the following conditions: Cognition, Cardiometabolic Risk Factors, Life Satisfaction.
What interventions are being tested in trial NCT06992544?
The interventions under investigation include: Pistachio-enriched diet (OTHER), Usual diet (OTHER).
Who is sponsoring clinical trial NCT06992544?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06992544 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06992544's enrollment target sits among peer trials
97 13th of 35 higher than 22 of 35 other Cognition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults
RECRUITING · NA
-
Nutrition to Support Postoperative Recovery
RECRUITING · NA
-
Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
RECRUITING · NA
-
The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
RECRUITING · NA
-
Identifying the Neural Correlates of Mental Simulation in Multi-Step Planning
RECRUITING · NA
-
Sleep Well Firefighters: An App-based Program to Improve Sleep, Cognition, and Behavioral Health in Firefighters
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI